Abiopharma

🔍 Lorenger Jeffrey D (Director)

Company: HNI CORP (HNI)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 4,671 shares of Common Stock at $38.68 per share (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 153,161.00 | transaction_form_type: 4
• Sold 4,671 shares of Common Stock at $50.0496 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 148,490.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 2,837 shares of Common Stock at $38.68 per share (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 151,327.00 | transaction_form_type: 4
• Sold 2,837 shares of Common Stock at $50.0831 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 148,490.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 27,131 shares of Common Stock at $38.68 per share (Direct)
  Date: 2026-08-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 175,621.00 | transaction_form_type: 4
• Sold 27,131 shares of Common Stock at $50.0901 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 148,490.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Acquired 12,445 shares of Common Stock at $38.68 per share (Direct)
  Date: 2026-08-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 160,935.00 | transaction_form_type: 4
• Sold 12,445 shares of Common Stock at $50.0878 per share (Direct)
  Date: 2026-08-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 148,490.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 313,061.46
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: Profit Sharing Retirement Plan | shares_owned_after: 7,674.19
• Sold 4,671 shares of Non-qualifying employee stock option (right to buy) at $38.68 per share (Derivative)
  Date: 2026-08-26 | Code: M | Expires: 2028-02-14 | Exercise: 2022-02-14 | equity_swap_involved: 0 | shares_owned_after: 70,965.00 | transaction_form_type: 4
• Sold 2,837 shares of Non-qualifying employee stock option (right to buy) at $38.68 per share (Derivative)
  Date: 2026-08-26 | Code: M | Expires: 2028-02-14 | Exercise: 2022-02-14 | equity_swap_involved: 0 | shares_owned_after: 68,128.00 | transaction_form_type: 4
• Sold 27,131 shares of Non-qualifying employee stock option (right to buy) at $38.68 per share (Derivative)
  Date: 2026-08-27 | Code: M | Expires: 2028-02-14 | Exercise: 2022-02-14 | equity_swap_involved: 0 | shares_owned_after: 40,997.00 | transaction_form_type: 4
• Sold 12,445 shares of Non-qualifying employee stock option (right to buy) at $38.68 per share (Derivative)
  Date: 2026-08-27 | Code: M | Expires: 2028-02-14 | Exercise: 2022-02-14 | equity_swap_involved: 0 | shares_owned_after: 28,552.00 | transaction_form_type: 4

Footnotes:

• F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026.
• F2: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 - $50.330, inclusive. The reporting person undertakes to provide HNI Corporation, any security holder of HNI Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 , 3 and 4 to this Form 4.
• F3: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.000 - $50.250, inclusive.
• F4: The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.000 - $50.270, inclusive.